Screening for Colon Cancer

Ames, IA US
April 15, 2026

Purpose

Mary Greeley Medical Center Grand Rounds is a multidisciplinary clinical activity that maintains, develops, or increases a physician's knowledge, skills, professional performance, and relationships to provide services for patients, the public, or the profession.

Target Audience

Physicians, advanced practice providers, nurses, medical students (rotating), non-medical students (rotating), and healthcare administrators.

Learning Objectives

  1. Review the use of non-invasive testing for colon cancer.
  2. Recognize when to suspect a hereditary colorectal cancer syndrome.

Speaker

Kirk J. Wangensteen, MD, PhD
Associate Professor of Medicine, Mayo Clinic School of Medicine, Gastrointestinal Neoplasia Clinic Director, Mayo Clinic

  • Medical School: University of Minnesota Medical School
  • PhD in Biochemistry, Molecular Biology, and Biophysics: University of Minnesota Medical School
  • Residency in Internal Medicine: University of Vermont Medical Center
  • Fellowship in Genetics: University of Pennsylvania
  • Fellowship in Gastroenterology and Hepatology: University of Pennsylvania

Full biography.

Course summary
Available credit: 
  • 1.00 AOA Category 2­A
Course opens: 
04/15/2026
Course expires: 
04/15/2026
Event starts: 
04/15/2026 - 12:10pm CDT
Event ends: 
04/15/2026 - 1:10pm CDT
Cost:
$0.00
Rating: 
0
Mary Greeley Medical Center
1111 Duff Ave.
Ames, IA 50010
United States
+1 (515) 239-2011

Accreditation Statements

  • DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.

EDUCATIONAL GRANTS

No ineligible company provided financial support for this continuing education activity.

DISCLOSURES

The speaker(s) will disclose if any pharmaceuticals, medical procedures, or devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers. 

Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.

    • Kirk J. Wangensteen, MD, PhD - Speaker

    CME Committee

    • No Mary Greeley Medical Center CME Committee member who planned this activity has any financial relationship to disclose relating to the content. 

    Gifts to the Mary Greeley Medical Center Foundation from Mary Greeley Medical Center, McFarland Clinic, and Availa Bank support this program. The content and selection of speaker(s) are the responsibility of the Mary Greeley Medical Center for Continuing Medical Education Committee, not the sponsors of this program.

    DISCLAIMER

    The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition. 

    Available Credit

    • 1.00 AOA Category 2­A

    Price

    Cost:
    $0.00
    Please login or Create an Account to take this course.